• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA 甲基化:肝纤维化的新治疗意义。

DNA methylation: new therapeutic implications for hepatic fibrosis.

机构信息

School of Pharmacy, Anhui Medical University, Hefei, 230032, China.

出版信息

Cell Signal. 2013 Jan;25(1):355-8. doi: 10.1016/j.cellsig.2012.10.007. Epub 2012 Oct 17.

DOI:10.1016/j.cellsig.2012.10.007
PMID:23085259
Abstract

DNA methylation refers to a heritable alteration in the pattern of gene expression that is regulated by a mechanism specifically not owing to changes in the primary nucleotide sequence. The transcriptional silencing caused by DNA methylation affects genes involved in the main cellular pathways: cell cycle control, Ras signaling, apoptosis, and detoxification. Recent studies have shown that methylation modifications orchestrate the activation of hepatic stellate cells (HSCs) characterized by excessive accumulation of extracellular matrices (ECMs). The activation of HSCs is mediated by multiple signal transduction pathways and is generally regarded as the major ECM producer responsible for liver fibrosis. In addition, aberrant methylation of specific gene involved in the activation of multiple signal transduction pathways in liver fibrosis. The aim of this review is to compile recent information on aberrant DNA methylation in hepatic fibrosis and to highlight key genes and molecular pathways in hepatic fibrosis formation.

摘要

DNA 甲基化是一种可遗传的基因表达模式改变,其调控机制特异性地不依赖于核苷酸序列的改变。DNA 甲基化引起的转录沉默影响了参与细胞主要途径的基因:细胞周期控制、Ras 信号转导、细胞凋亡和解毒。最近的研究表明,甲基化修饰协调了肝星状细胞(HSCs)的激活,其特征是细胞外基质(ECMs)的过度积累。HSCs 的激活是由多种信号转导途径介导的,通常被认为是导致肝纤维化的主要 ECM 产生者。此外,在肝纤维化中涉及多个信号转导途径的特定基因的异常甲基化。本综述的目的是汇集肝纤维化中异常 DNA 甲基化的最新信息,并强调肝纤维化形成中的关键基因和分子途径。

相似文献

1
DNA methylation: new therapeutic implications for hepatic fibrosis.DNA 甲基化:肝纤维化的新治疗意义。
Cell Signal. 2013 Jan;25(1):355-8. doi: 10.1016/j.cellsig.2012.10.007. Epub 2012 Oct 17.
2
The potential of microRNAs in liver fibrosis.微小 RNA 在肝纤维化中的作用。
Cell Signal. 2012 Dec;24(12):2268-72. doi: 10.1016/j.cellsig.2012.07.023. Epub 2012 Aug 3.
3
Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of κB kinase α/inhibitor of κB-α/nuclear factor-κB pathway.吲哚-3-甲醇通过阻断κB 激酶α/κB 抑制蛋白-α/核转录因子-κB 通路增强大鼠肝纤维化的消退并刺激肝星状细胞凋亡。
J Pharmacol Exp Ther. 2011 Nov;339(2):694-703. doi: 10.1124/jpet.111.179820. Epub 2011 Aug 23.
4
New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery.DNA 甲基化在肝纤维化中的新进展,特别强调 microRNAs 和 DNA 甲基化机制之间的串扰。
Cell Signal. 2013 Sep;25(9):1837-44. doi: 10.1016/j.cellsig.2013.05.017. Epub 2013 May 22.
5
Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis.由DNMT3a介导的Septin9甲基化增强肝星状细胞激活和肝纤维化。
Toxicol Appl Pharmacol. 2017 Jan 15;315:35-49. doi: 10.1016/j.taap.2016.12.002. Epub 2016 Dec 6.
6
Epigenetic regulation of hepatic stellate cell activation and liver fibrosis.肝星状细胞激活与肝纤维化的表观遗传调控
Expert Rev Gastroenterol Hepatol. 2016 Dec;10(12):1397-1408. doi: 10.1080/17474124.2016.1251309. Epub 2016 Nov 2.
7
New advances of DNA/RNA methylation modification in liver fibrosis.DNA/RNA 甲基化修饰在肝纤维化中的新进展。
Cell Signal. 2022 Apr;92:110224. doi: 10.1016/j.cellsig.2021.110224. Epub 2021 Dec 24.
8
DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats.DNMT1 介导的 PTEN 高甲基化赋予大鼠肝星状细胞激活和肝纤维化。
Toxicol Appl Pharmacol. 2012 Oct 1;264(1):13-22. doi: 10.1016/j.taap.2012.06.022. Epub 2012 Jul 25.
9
Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis.肝星状细胞中的表观遗传修饰有助于肝纤维化。
Tohoku J Exp Med. 2013 Jan;229(1):35-43. doi: 10.1620/tjem.229.35.
10
Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential.激活的星状细胞清除用于肝纤维化消退:分子基础和转化潜力。
Biomed Pharmacother. 2013 Apr;67(3):246-50. doi: 10.1016/j.biopha.2012.10.002. Epub 2012 Nov 15.

引用本文的文献

1
Transcriptional regulation of Glis2 in hepatic fibrosis.Glis2 在肝纤维化中的转录调控。
Exp Mol Med. 2023 Jul;55(7):1462-1478. doi: 10.1038/s12276-023-01031-y. Epub 2023 Jul 3.
2
Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease.经活检证实的非酒精性脂肪性肝病患者肝纤维化诊断的潜在血液DNA甲基化生物标志物基因
Front Med (Lausanne). 2022 Mar 31;9:864570. doi: 10.3389/fmed.2022.864570. eCollection 2022.
3
Epigenetic regulation of cellular functions in wound healing.
细胞功能在创伤愈合中的表观遗传调控。
Exp Dermatol. 2021 Aug;30(8):1073-1089. doi: 10.1111/exd.14325. Epub 2021 Apr 1.
4
Antifibrotics in liver disease: are we getting closer to clinical use?抗肝纤维化药物:我们离临床应用更近了吗?
Hepatol Int. 2019 Jan;13(1):25-39. doi: 10.1007/s12072-018-9897-3. Epub 2018 Oct 9.
5
EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis.EZH2 介导的 Dkk1 抑制促进肝星状细胞激活和肝纤维化。
J Cell Mol Med. 2017 Oct;21(10):2317-2328. doi: 10.1111/jcmm.13153. Epub 2017 Mar 23.
6
Association between Promoter Hypomethylation and Overexpression of Autotaxin with Outcome Parameters in Biliary Atresia.自分泌运动因子启动子低甲基化与过表达和胆道闭锁预后参数之间的关联
PLoS One. 2017 Jan 4;12(1):e0169306. doi: 10.1371/journal.pone.0169306. eCollection 2017.
7
Hypoxia-Induced Changes in DNA Methylation Alter RASAL1 and TGFβ1 Expression in Human Trabecular Meshwork Cells.缺氧诱导的DNA甲基化变化改变人小梁网细胞中RASAL1和TGFβ1的表达
PLoS One. 2016 Apr 28;11(4):e0153354. doi: 10.1371/journal.pone.0153354. eCollection 2016.
8
Epigenetic Changes during Hepatic Stellate Cell Activation.肝星状细胞激活过程中的表观遗传变化。
PLoS One. 2015 Jun 12;10(6):e0128745. doi: 10.1371/journal.pone.0128745. eCollection 2015.
9
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease.非酒精性脂肪性肝病和酒精性肝病中参与纤维化进展的基因的差异性DNA甲基化
Clin Epigenetics. 2015 Mar 14;7(1):25. doi: 10.1186/s13148-015-0056-6. eCollection 2015.
10
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.肝纤维化发病机制中的细胞与分子机制:最新进展
World J Gastroenterol. 2014 Jun 21;20(23):7260-76. doi: 10.3748/wjg.v20.i23.7260.